- Association of progressive multifocal leukoencephalopathy lesion volume with JC virus polymerase chain reaction results in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis
- Pooled analyses of phase III studies of ADS-5102 (amantadine) extended-release capsules for dyskinesia in Parkinson’s disease
- Effect of treating acute optic neuritis with bioequivalent oral vs intravenous corticosteroids: A randomized clinical trial
- NGM282 for treatment of non-alcoholic steatohepatitis: A multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
- Long-term effectiveness of tocilizumab in patients with rheumatoid arthritis, stratified by number of previous treatment failures with biologic agents: Results from the German RABBIT cohort
- Safety and efficacy of pembrolizumab monotherapy in patients with previously treated advanced gastric and gastroesophageal junction cancer: Phase 2 clinical KEYNOTE-059 trial
- Biosimilar vs originator insulins: Systematic review and meta-analysis
- Administering atropine and ketamine before less invasive surfactant administration resulted in low pain scores in a prospective study of premature neonates
- The safety and effectiveness profile of eldecalcitol in a prospective, post-marketing observational study in Japanese male patients with osteoporosis
- Adverse drug events associated with low-dose (10 mg) vs high-dose (25 mg) empagliflozin in patients treated for type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials
- Adalimumab treatment of anti-TNF-naive patients with ulcerative colitis: Deep remission and response factors
- Efficacy and safety of transarterial chemoembolization plus external beam radiotherapy vs sorafenib in hepatocellular carcinoma with macroscopic vascular invasion: A randomized clinical trial
- Effects of denosumab on bone mineral density in Japanese women with osteoporosis treated with aromatase inhibitors for breast cancer
- Adalimumab reduces extraintestinal manifestations in patients with Crohn's disease: A pooled analysis of 11 clinical studies
- Effects of adjunctive N-acetylcysteine on depressive symptoms: Modulation by baseline high-sensitivity C-reactive protein
Feed Sources
